A new series of 27 diethyl 2-(phenylcarbamoyl)phenyl phosphorothioates (thiophosphates) was synthesized, characterized by NMR, IR and CHN analyses and evaluated against Mycobacterium tuberculosis H 37 Rv, Mycobacterium avium and two strains of Mycobacterium kansasii. The best activity against M. tuberculosis was found for O- {4-bromo-2-[(3,4-dichlorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (minimum inhibitory concentration of 4 µM). The highest activity against nontuberculous mycobacteria was exhibited by O-(5-chloro-2-{[4-(trifluoromethyl)phenyl]carbamoyl}-phenyl) O,O-diethyl phosphorothioate with MIC values from 16 µM. Prepared thiophosphates were also evaluated against acetylcholinesterase from electric eel and butyrylcholinesterase from equine serum. Their inhibitory activity was compared to that of the known cholinesterases inhibitors galanthamine and rivastigmine. All tested compounds showed a higher (for AChE inhibition) and comparable (for BChE inhibition) activity to that of rivastigmine, with IC 50 s within the 8.04 to 20.2 µM range.
Introduction
Tuberculosis (TB) is an infectious disease caused by intracellular pathogen Mycobacterium tuberculosis (Mtb). In the past, the occurrence of TB decreased thanks to the progress in medical care and therapeutic options, but nowadays, affecting more than eight million people worldwide, TB is once again considered to be a global health problem. In 2012, 1.3 million people died from the disease [1] . The rise of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) cases and the co-infection with HIV are the main reasons for its recurrence. Demanding pharmacological treatment and urgent need for new antimycobacterial agents present serious challenges, stimulating research in this area.
A series of salicylanilide diethyl phosphates, previously synthesized by our group [2] , showed an increased antimycobacterial activity, a decreased cytotoxicity and improved selectivity indices in comparison with the parent salicylanilides. Some of the compounds were also found to inhibit multidrug-resistant Mtb strains with a minimum inhibitory concentration (MIC) of 1 µM. We have concluded that temporary masking of the free hydroxyl group of salicylanilide compounds may increase/be beneficial for its possible usage and the formation of this kind of prodrug is an attractive strategy for an efficient cellular internalization [2] .
In previous studies, the synthesis of thiophosphates has been involved in the synthesis of potential immunotherapeutic oligonucleotide prodrugs [3] , thermolytic DNA prodrugs [4] and the synthesis of thiophosphate esters of 2'-C-methyl ribonucleosides used as inhibitors of RNA-dependent RNA polymerase of hepatitis C virus [5] . This structure modification served as an inspiration for the incorporation of sulphur into the phosphate moiety and preparation of thioanalogues with increased lipophilicity-O,O-diethyl O- [2-(phenylcarbamoyl) phenyl] phosphorothioates (salicylanilide diethyl thiophosphates).
Compounds with phosphonic, phosphoric or thiophosphoric moieties in their structures are well-known anticholinesterase agents. They act as irreversible inhibitors of both acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) [6] . The role of AChE in the cholinergic synapsis is the termination of cholinergic impulse by hydrolysis of acetylcholine (ACh), a neurotransmitter present in central and peripheral nervous system [7] . With the inhibition of AChE, the level of ACh in the synaptic junction increases, enhancing thus cholinergic transmission. Reversible inhibitors of AChE are used in the treatment of various diseases, requiring a longer duration of ACh action on postsynaptic receptors (e.g., myasthenia gravis, Alzheimer's disease) [8, 9] . However, the irreversible inhibition by organophosphorus compounds can graduate into cholinergic crisis leading to overstimulation of cholinergic receptors which can be life-threatening. In pathological states accompanied by AChE depletion, BChE can partially compensate its regulatory function. Lacking the high specificity for the substrate, BChE is also a very important detoxicating protein, acting as a scavenger of esteratic exogenous compounds. However, its principal role in the organism still remains unclear [10] . Organophosphorus irreversible inhibitors express a strong inhibitory activity of both AChE and BChE, resulting from the formation of covalent bond between the organophosphorus compound and active site serine of the enzyme [11] . Similarity in thiophosphate moiety led us to evaluate our salicylanilide thiophosphates also against both of these enzymes. This assumption was supported by the fact that salicylanilide carbamates were reported as cholinesterases inhibitors [12] .
Based on presented facts, we evaluated salicylanilide diethyl thiophosphates as potential antimycobacterial drugs (salicylanilide derivatives) and anticholinesterase agents (dialkyl aryl phosphorothioate moiety).
Results and Discussion

Chemistry
The synthetic approach to the preparation of the diethyl (2-phenylcarbamoyl)phenyl thiophosphates (phosphorothioates) 1 is depicted in Scheme 1. It is similar to the one used earlier for the synthesis of salicylanilide diethyl phosphates [2] . Starting salicylanilides were routinely obtained by the reaction of 4/5-chloro and 5-bromosalicylic acids with the appropriate anilines mediated by PCl 3 in chlorobenzene using a microwave reactor [13] . Salicylanilides were esterified by O,O-diethyl phosphorochloridothioate in the presence of triethylamine in dichloromethane (DCM). The synthesis, subsequent isolation and purification gave yields within the 38%-93% range. 
In Vitro Antimycobacterial Activity
Antimycobacterial activity was tested in vitro against Mycobacterium tuberculosis strain 331/88 (H 37 Rv), Mycobacterium avium 330/88, Mycobacterium kansasii 235/80 and Mycobacterium kansasii 6509/96, a strain isolated from a patient. The minimum inhibitory concentration values are presented in the Table 1 .
According to the substitution in the salicylic part of the molecule, the tested compounds could be divided into three groups: Group 1 includes 4-Br derivatives 1a-i; Group 2 includes 4-Cl derivatives 1j-r; and Group 3 contains 5-Cl derivatives 1s-1zz. It was observed, that halogenation of the position 4 of salicylic part positively contributes to the antimycobacterial activity. This finding correlates with our previous results [2] . , 1q) , 4-trifluoromethyl (1i, 1r) and 3,4-dichloro (1l) derivatives also showed significant MIC of 8 µM. Even though the structure-activity relationships are in correlation with salicylanilide diethyl phosphates [2] , diethyl thiophosphate compounds expressed only moderate antimycobacterial activity against Mtb and atypical mycobacteria. The introduction of sulphur into the phosphate group did not meet our expectations about increased antimycobacterial activity, not only against Mtb, but also against M. avium and M. kansasii, which were inhibited even at higher concentrations (≥ 16 µM) than Mtb. The best activity against these last mentioned strains was described for 1zz. M. avium showed the lowest susceptibility to salicylanilide phosphates with MIC values ≥ 62.5 µM.
None of the diethyl thiophosphates 1 exhibited the activity similar to isoniazid (INH) against M. tuberculosis and one strain of M. kansasii (6509/96). On the other hand, ten salicylanilide derivatives (1d, 1e, 1h, 1i, 1s, 1t, 1w-1y, and 1zz) were significantly more active against INH-resistant M. avium (with all MIC values ≤ 250 μM) and fourteen molecules (1d, 1e, 1h, 1i, 1k, 1r-1x 
In Vitro AChE a BChE Inhibition
The ability of the tested compounds to inhibit AChE from electric eel (Electrophorus electricus L.) and BChE from equine serum was screened in vitro using modified Ellman's method for the evaluation of cholinesterase activity. The effectiveness of the inhibitors is expressed as IC 50 , representing the concentration of an inhibitor required for 50% inhibition of the enzyme. The activities of the tested compounds were compared with standards rivastigmine and galanthamine (Table 2 ). These two standards were chosen due to their different structures. Rivastigmine is an acylating pseudo-reversible carbamate inhibitor of cholinesterases that inhibits AChE as well as BChE, while galanthamine is a non-acylating competitive reversible cholinesterase inhibitor. Furthermore, galanthamine acts as an allosteric ligand at nicotinic acetylcholine receptors. The choice of these drugs with different mechanism of action can provide relevant results. All tested compounds expressed a good inhibitory activity with IC 50 s in low micromolar values. These values are summarized in Table 2 .
It is possible to conclude that most of the tested compounds inhibit AChE somewhat better than BChE. Derivatives of Group 2 (R = 4-Cl) and Group 3 (R = 5-Cl) are more effective inhibitors of AChE than derivatives of Group 1 (R = 4-Br). For Groups 1 and 3, the relationship is inverse when compared to anti-TB activity. AChE and BChE inhibition is expressed as mean ± SD (n = 3 experiments). The best values for each enzyme are given in bold. The values of IC 50 of rivastigmine and galanthamine were published previously [14] .
As in the case of the inhibition of BChE, there is no observed effect of aniline substitution by chlorine or bromine on the power of inhibition. Both 3-and 4-fluorine represent the most convenient substitution patterns for the aniline ring for BChE (1f, 1g, 1o, 1p, and especially 1x and 1y). However, IC 50 s of all derivatives are within a narrow concentration range (8-20 µM) without any sharp differences. We presume that this is a consequence of their mechanism of action-irreversible phosphorylation of enzyme active site; from this point of view, salicylanilide core serves as a carrier of phosphorylating agents. In general, the IC 50 values of all diethyl thiophosphates 1 were within a narrow concentration range without any sharp differences: 8. 
Experimental Section
General Information
Solvents and reagents were purchased from Sigma-Aldrich (Darmstadt, Germany) and Penta Chemicals (Prague, Czech Republic) and were used as received. Reactions were monitored by thin-layer chromatography (TLC) using commercially available coated plates (Merck Kieselgel 60 F254 silica) with UV light (256 nm) visualization. The melting points were determined on a Büchi Melting Point B-540 apparatus (Bűchi Labortechnik AG, Flawil, Switzerland) using open capillaries and were uncorrected. IR spectra were recorded on a Nicolet 6700 FT-IR spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) in the range of 400-4000 cm 
Chemistry General Procedure for the Synthesis of Diethyl (2-phenylcarbamoyl)thiophosphates
Appropriate salicylanilide (2.0 mmol) was suspended at 20 °C in dichloromethane (10 mL) and then 1.5 equivalents of triethylamine (0.418 mL; 3.0 mmol) were added under vigorous stirring. After 5 min, 1.2 equivalents of O,O-diethyl phosphorochloridothioate (0.347 mL) was added to the mixture. The mixture was stirred at the room temperature for 2 h; the reaction was monitored by TLC using a 4:1 toluene/ethyl acetate mixture as eluent. After this time, the solution was added to a chromatography column using chloroform or chloroform/hexane 9:1 as eluent. The solvent was removed under reduced pressure to obtain the product, which was recrystallized from acetone-hexane, if necessary. 
O-{4-Bromo-2-[(3-chlorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1a
O-{4-Bromo-2-[(4-fluorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1g)
.
O-(4-Bromo-2-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl) O,O-diethyl phosphorothioate (1h).
Yield: 38%, oily liquid; IR: 1677 (amide I), 1606 (ν CC aromatic ), 1537 (amide II), 1492, 1472 (ν CC aromatic ) cm 
O-(4-Bromo-2-{[4-(trifluoromethyl)phenyl]carbamoyl}phenyl) O,O-diethyl phosphorothioate (1i
O-{4-Chloro-2-[(3-chlorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1j
O-{4-Chloro-2-[(4-chlorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1k)
O-{4-Chloro-2-[(3,4-dichlorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1l)
O-{2-[(3-Bromophenyl)carbamoyl]-4-chlorophenyl} O,O-diethyl phosphorothioate (1m
O-{4-Chloro-2-[(3-fluorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1o)
O-(4-Chloro-2-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl) O,O-diethyl phosphorothioate (1q
O-{5-Chloro-2-[(3-chlorophenyl)carbamoyl]phenyl} O,O-diethyl phosphorothioate (1s)
Determination of IC 50 s for Cholinesterases
The IC 50 values were determined using the spectrophotometric Ellman's method, which is a simple, rapid and direct method to determine the SH and -S-S-group content in proteins [16] . This method is widely used for cholinesterase activity evaluation and screening of the efficiency of cholinesterase inhibitors. Cholinesterase activity is measured indirectly by quantifying the concentration of 5-thio-2-nitrobenzoic acid (TNB) ion formed in the reaction between the thiol reagent 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) and thiocholine, a product of substrate hydrolysis by cholinesterase (i.e., acetylthiocholine, ATCh) [17] . All the tested compounds were dissolved in dimethyl sulfoxide (concentration 0.01 M) and then diluted in demineralised water (concentration 0.001 M and 0.0001 M). The Ellman's method is slightly modified according to Zdrazilova et al. [14] . Acetylcholinesterase was obtained from electric eel (Electrophorus electricus L.) and butyrylcholinesterase from equine serum.
Conclusions
A series of 27 new salicylanilide derivatives containing diethyl thiophosphate moieties was synthesized with the goal of improving the antimycobacterial activity of salicylanilide diethyl phosphates as potential salicylanilide prodrugs presented earlier. However, the expected improvement was not achieved. Derivatives of 5-bromosalicylic acid, 3,4-dichloroaniline, 3-and 4-(trifluoromethyl)aniline exhibited superior antimycobacterial activity. The thiophosphate moiety also inspired us to evaluate this series against acetylcholinesterase and butyrylcholinesterase. All the discussed compounds expressed a significant inhibition of both AChE and BChE. Their activities were compared to those of the known acetylcholinesterase inhibitors galanthamine and rivastigmine. All tested compounds showed higher or comparable activity to that of rivastigmine and slightly lower than that of galanthamine. IC 50 values for salicylanilide diethyl thiophosphates were found to be similar for all of the compounds and also for both AChE and BChE. We demonstrated unequivocally that salicylanilide diethyl thiophosphates share dual biological activity as inhibitors of both cholinesterases and various mycobacteria. Obviously, there is no correlation between both activities. It is a result of different expected mechanisms of action and the active part of the molecule: the salicylanilide scaffold confers antimicrobial activity preferentially, but the cholinesterase inhibition arises from the presence of the thiophosphate moiety.
